SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-020117
Filing Date
2019-10-10
Accepted
2019-10-10 16:10:20
Documents
1
Period of Report
2019-10-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9373
  Complete submission text file 0001213900-19-020117.txt   10906
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11 COMMERCE DRIVE 11TH FLOOR CRANFORD NJ 07016
Business Address
Holuka Eugene Myron (Reporting) CIK: 0001678292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38174 | Film No.: 191146287